On the public citation graph
Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India
0 signed · 80 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.298.16.1934openalex-snapshot
Leveraging University Research to Advance Global Health
inferredcites →https://doi.org/10.1002/jps.21364openalex-snapshot
PATH's Approach to Product Introduction in Developing Countries
inferredcites →https://doi.org/10.1007/3-7643-7381-4openalex-snapshot
The Grand Challenge for the Future : Vaccines for Poverty-Related Diseases from Bench to Field
inferredcites →https://doi.org/10.1007/3-7643-7381-4_4openalex-snapshot
New approaches towards development, production and use of developing-country market vaccines in developing countries
inferredcites →https://doi.org/10.1016/j.biotechadv.2005.06.004openalex-snapshot
Challenges and opportunities for enhancing biotechnology and technology transfer in developing countries
inferredcites →https://doi.org/10.1016/j.vaccine.2003.04.001openalex-snapshot
The introduction of new vaccines into developing countries
inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.042openalex-snapshot
Chapter 26: Innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries
inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.119openalex-snapshot
Chapter 11: HPV vaccines: Commercial Research & Development
inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.123openalex-snapshot
Chapter 17: Second generation HPV vaccines to prevent cervical cancer
inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.128openalex-snapshot
Chapter 15: HPV vaccine use in the developing world.
inferredcites →https://doi.org/10.1016/j.vaccine.2007.09.007openalex-snapshot
Access to vaccine technologies in developing countries: Brazil and India
inferredcites →https://doi.org/10.1016/j.vaccine.2008.05.005openalex-snapshot
Human Papillomavirus Infection and Cervical Cancer Prevention in India, Bangladesh, Sri Lanka and Nepal
inferredcites →https://doi.org/10.1016/j.vaccine.2008.10.015openalex-snapshot
Introducing new vaccines in the poorest countries: What did we learn from the GAVI experience with financial sustainability?
inferredcites →https://doi.org/10.1016/s0968-8080(08)32409-4openalex-snapshot
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications
inferredcites →https://doi.org/10.1038/nbt0907-976openalex-snapshot
NIH forges R&D partnerships in developing countries
inferredcites →https://doi.org/10.1038/sj.bjc.6604462openalex-snapshot
Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
inferredcites →https://doi.org/10.1056/nejmp078053openalex-snapshot
Introducing HPV Vaccine in Developing Countries — Key Challenges and Issues
inferredcites →https://doi.org/10.1093/jnci/djp106openalex-snapshot
Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
inferredcites →https://doi.org/10.1126/science.320.5878.860openalex-snapshot
Price Is the Main Barrier to Wider Use of Papillomavirus Vaccine
inferredcites →https://doi.org/10.1128/cvi.00164-07openalex-snapshot
Salmonella enterica Serovar Typhi Ty21a Expressing Human Papillomavirus Type 16 L1 as a Potential Live Vaccine against Cervical Cancer and Typhoid Fever
inferredcites →https://doi.org/10.1172/jci28607openalex-snapshot
Prophylactic human papillomavirus vaccines
inferredcites →https://doi.org/10.1177/009885880903500205openalex-snapshot
Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?
inferredcites →https://doi.org/10.1186/1744-8603-3-1openalex-snapshot
Closing the access gap for health innovations: an open licensing proposal for universities
inferredcites →https://doi.org/10.1345/aph.1n040openalex-snapshot
Global Progress Toward Universal Childhood Hepatitis B Vaccination, 2003
inferredcites →https://doi.org/10.1371/journal.pmed.0050132openalex-snapshot
Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities
inferredcites →https://doi.org/10.1377/hlthaff.25.4.1061openalex-snapshot
The Impact Of Globalization On Vaccine Development And Availability
inferredcites →https://doi.org/10.1377/hlthaff.27.1.130openalex-snapshot
Market-Based Licensing For HPV Vaccines In Developing Countries
inferredcites →https://doi.org/10.1377/hlthaff.27.1.140openalex-snapshot
The GO License: Only Part Of The Solution
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4647589openalex-extracted
Non-singular Logics of Intellectual Property in Biomedical Innovation
inferred← citeshttps://doi.org/10.1002/ijgo.12186openalex-snapshot
Progress in HPV vaccination in low‐ and lower‐middle‐income countries
inferred← citeshttps://doi.org/10.1002/ijgo.12656openalex-snapshot
Making HPV vaccination available to girls everywhere
inferred← citeshttps://doi.org/10.1007/978-1-0716-1892-9_29openalex-snapshot
Vaccine Intellectual Property
inferred← citeshttps://doi.org/10.1007/978-3-031-62558-9_2openalex-snapshot
Progression Pathways of Human Papillomavirus-Associated Cancer
inferred← citeshttps://doi.org/10.1007/978-3-031-83868-2_13openalex-snapshot
COVID-19 and the Global South: An Integrative Review
inferred← citeshttps://doi.org/10.1007/978-981-95-8349-2_2openalex-snapshot
Vaccine Innovation Histories Through Socio-technological Lens
inferred← citeshttps://doi.org/10.1007/s12257-012-0067-5openalex-snapshot
Effects of downstream processing on structural integrity and immunogenicity in the manufacture of papillomavirus type 16 L1 virus-like particles
inferred← citeshttps://doi.org/10.1007/s40011-011-0014-9openalex-snapshot
Viral Vaccines in India: An Overview
inferred← citeshttps://doi.org/10.1016/b978-0-12-814457-2.00028-3openalex-snapshot
General Introduction—The Background to Human Papillomavirus and Cancer Research
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106699openalex-snapshot
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.03.052openalex-snapshot
Patent data mining: A tool for accelerating HIV vaccine innovation
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.04.124openalex-snapshot
An international technology platform for influenza vaccines
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.07.071openalex-snapshot
Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles
inferred← citeshttps://doi.org/10.1016/j.xphs.2022.11.021openalex-snapshot
Multi-dose Formulation Development for a Quadrivalent Human Papillomavirus Virus-Like Particle-Based Vaccine: Part II- Real-time and Accelerated Stability Studies
inferred← citeshttps://doi.org/10.1016/s1470-2045(14)71179-9openalex-snapshot
Next generation prophylactic human papillomavirus vaccines
inferred← citeshttps://doi.org/10.1016/s2214-109x(19)30065-8openalex-snapshot
Gender-neutral HPV vaccination in Africa – Authors' reply
inferred← citeshttps://doi.org/10.1038/nbt.3244openalex-snapshot
Access to new technologies in multipatented vaccines: challenges for Brazil
inferred← citeshttps://doi.org/10.1038/nbt0212-193fopenalex-snapshot
Erratum: Corrigendum: Intellectual property, technology transfer and manufacture of low-cost HPV vaccines in India
inferred← citeshttps://doi.org/10.1057/jphp.2013.4openalex-snapshot
Does India need an indigenous HPV vaccine and why?
inferred← citeshttps://doi.org/10.1057/s41285-026-00266-9openalex-snapshot
Reconfiguring scientific competition: patent consolidation and the access politics of the HPV vaccine
inferred← citeshttps://doi.org/10.1097/pat.0b013e32834d7bd8openalex-snapshot
Prophylactic human papillomavirus vaccines: past, present and future
inferred← citeshttps://doi.org/10.1177/0162243917749728openalex-snapshot
Situated Practice and the Emergence of Ethical Research
inferred← citeshttps://doi.org/10.1177/2051013617733259openalex-snapshot
It is time to accelerate building local vaccine adjuvant manufacturing capacity
inferred← citeshttps://doi.org/10.1186/1475-9276-10-27openalex-snapshot
Global challenges of implementing human papillomavirus vaccines
inferred← citeshttps://doi.org/10.1186/s12992-020-00552-9openalex-snapshot
Public-private knowledge transfer and access to medicines: a systematic review and qualitative study of perceptions and roles of scientists involved in HPV vaccine research
inferred← citeshttps://doi.org/10.12927/hcpol.2022.26827openalex-snapshot
Authors' Response – A Status Quo of Failure: Time to Fix University Technology Transfer to Address Global Health
inferred← citeshttps://doi.org/10.12927/hcpol.2022.26830openalex-snapshot
University Technology Transfer Has Failed to Improve Access to Global Health Products during the COVID-19 Pandemic
inferred← citeshttps://doi.org/10.1371/journal.pone.0164000openalex-snapshot
Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries
inferred← citeshttps://doi.org/10.1371/journal.pone.0225496openalex-snapshot
Glutathione contributes to efficient post-Golgi trafficking of incoming HPV16 genome
inferred← citeshttps://doi.org/10.1371/journal.pone.0244722openalex-snapshot
The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value
inferred← citeshttps://doi.org/10.1377/hlthaff.2015.1411openalex-snapshot
Current Global Pricing For Human Papillomavirus Vaccines Brings The Greatest Economic Benefits To Rich Countries
inferred← citeshttps://doi.org/10.1517/13543776.2011.551114openalex-snapshot
Advances in human papilloma virus vaccines: a patent review
inferred← citeshttps://doi.org/10.19088/k4d.2021.034openalex-snapshot
Economic Impact of Local Vaccine Manufacturing
inferred← citeshttps://doi.org/10.2105/ajph.2014.302236openalex-snapshot
Improving Global Access to New Vaccines: Intellectual Property, Technology Transfer, and Regulatory Pathways
inferred← citeshttps://doi.org/10.2105/ajph.2014.302236ropenalex-snapshot
Improving Global Access to New Vaccines: Intellectual Property, Technology Transfer, and Regulatory Pathways
inferred← citeshttps://doi.org/10.2105/ajph.2014.302236sopenalex-snapshot
Mejorar el acceso mundial a las nuevas vacunas: propiedad intelectual, transferencia de tecnología y vías de reglamentación
inferred← citeshttps://doi.org/10.2190/iq.31.1.fopenalex-snapshot
Implementing HPV Vaccines: Public Knowledge, Attitudes, and the Need for Education
inferred← citeshttps://doi.org/10.30574/gscarr.2020.3.1.0023openalex-snapshot
Provider recommendations for human papillomavirus vaccine (HPV) among adolescent males in Southwest Georgia counties and the associated HPV prevalence in this population
inferred← citeshttps://doi.org/10.30649/htlj.v4i2.13openalex-snapshot
Application of Parallel Importation and Voluntary License in the Covid-19 Vaccines Patent as a Strategy for Handling the Health Emergency Situations in Indonesia
inferred← citeshttps://doi.org/10.30649/htlj.v4i2.185openalex-snapshot
Application of Parallel Importation and Voluntary License in the Covid-19 Vaccines Patent as a Strategy for Handling the Health Emergency Situations in Indonesia
inferred← citeshttps://doi.org/10.30895/2312-7821-2020-8-3-141-150openalex-snapshot
Ongoing challenges and future directions of human papillomavirus vaccination
inferred← citeshttps://doi.org/10.3389/fimmu.2018.00026openalex-snapshot
Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution
inferred← citeshttps://doi.org/10.3390/iecp2020-08653openalex-snapshot
Sub-100 nm Chitosan-Triphosphate-DNA Nanoparticles for Delivery of DNA Vaccines
inferred← citeshttps://doi.org/10.3390/vaccines13101006openalex-snapshot
Productivity Improvement of Human Papillomavirus-like Particles in Insect Cells Using Hyper-Expression Baculovirus Vector
inferred← citeshttps://doi.org/10.3390/vaccines8020316openalex-snapshot
Defining Elimination of Genital Warts—A Modified Delphi Study
inferred← citeshttps://doi.org/10.4103/2468-6360.198797openalex-snapshot
A case study of Gavi'S human papillomavirus vaccine support programme
inferred← citeshttps://doi.org/10.4103/pmrr.pmrr_16_23openalex-snapshot
Cervical Cancer and Human Papilloma Virus (HPV) Vaccines: A primer for General Physicians
inferred← citeshttps://doi.org/10.51415/10321/782openalex-snapshot
Intellectual property management and protection : low intellectual property registration at universities : a case study of the Durban University of Technology
inferred← citeshttps://doi.org/10.56557/upjoz/2024/v45i164320openalex-snapshot
Animal Biotechnology and Intellectual Property Rights: A Comprehensive Analysis
inferred← citeshttps://doi.org/10.7314/apjcp.2015.16.15.6193openalex-snapshot
Roles of Human Papillomaviruses and p16 in Oral Cancer
inferred← citeshttps://doi.org/10.7774/cevr.2014.3.2.168openalex-snapshot
Current status of human papillomavirus vaccines
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.